Schizophrenia Spectrum Disorders Study Guide: Criteria, Etiology, Risk Factors, Differential Diagnosis and Gestalt Therapy

Module 11: Schizophrenia Spectrum Disorders Study Guide and Gestalt Therapy

After the assigned readings and schizophrenia content, create a study guide of at least four pages (excluding title and references) demonstrating thorough understanding of all schizophrenia spectrum disorders: criteria, etiology, risk factors, differential diagnosis and related content. Also report on the founders and techniques of Gestalt therapy in 150 words.

Full APA 7th edition; at least five peer-reviewed references from North American journals published 2021 to 2026.

Original example for study purposes (about 1,300 words, roughly five to six double-spaced pages with the table). Confirm criteria against your DSM-5-TR course access and add your assigned readings.

Overview

Schizophrenia spectrum and other psychotic disorders are defined by abnormalities in one or more of five domains: delusions, hallucinations, disorganized thinking (speech), grossly disorganized or abnormal motor behavior (including catatonia) and negative symptoms (American Psychiatric Association [APA], 2022). Disorders on the spectrum differ mainly in symptom type, duration and the presence of mood episodes. Schizophrenia affects roughly 1% of people over a lifetime, typically begins in late adolescence or early adulthood and is one of the leading causes of disability worldwide (Crawford & Go, 2022).

Key Symptom Domains

• Delusions: fixed false beliefs not amenable to change despite conflicting evidence (persecutory, referential, grandiose, erotomanic, nihilistic, somatic).
• Hallucinations: perception-like experiences without an external stimulus, most commonly auditory voices.
• Disorganized speech: derailment, tangentiality or incoherence (“word salad”).
• Grossly disorganized or catatonic behavior: unpredictable agitation, inappropriate behavior, or catatonia (stupor, posturing, mutism, negativism).
• Negative symptoms: diminished emotional expression and avolition, plus alogia, anhedonia and asociality (Crawford & Go, 2022).

Diagnostic Criteria by Disorder

Course specifiers for schizophrenia include first episode or multiple episodes (currently in acute episode, partial remission or full remission) and continuous, with optional specifiers for catatonia and current severity (APA, 2022).

Etiology

Neurodevelopmental model. Current evidence views schizophrenia as the late result of disruptions in brain development. Many people who later develop schizophrenia show subtle cognitive, motor and social deficits in childhood, and adolescence brings excessive synaptic pruning and changes in cortical maturation that may unmask vulnerability (Forsyth & Bearden, 2023). Genetics play a major role: schizophrenia is highly polygenic, with common and rare variants converging on synaptic signaling genes, including complement component 4 (C4) variants that may increase synaptic pruning, and high-penetrance risks such as the 22q11.2 deletion (Forsyth & Bearden, 2023). Neurotransmitter hypotheses include excess dopamine activity in mesolimbic pathways (linked to positive symptoms, and the target of antipsychotics), reduced dopamine in mesocortical pathways (linked to negative and cognitive symptoms) and glutamate (NMDA receptor) hypofunction. Brain imaging shows enlarged ventricles and reduced gray matter in some patients, but there is no diagnostic biomarker (Crawford & Go, 2022).

Risk Factors

• Family history: risk rises substantially with an affected first-degree relative.
• Prenatal and perinatal factors: maternal infection, malnutrition and obstetric complications such as neonatal hypoxia (Crawford & Go, 2022).
• Cannabis use, especially heavy adolescent use of high-potency cannabis, which interacts with genetic vulnerability (Forsyth & Bearden, 2023).
• Social determinants: childhood adversity, social disconnection, racism and discrimination, urban upbringing and low socioeconomic status, migration, homelessness, food insecurity and incarceration are associated with higher incidence and poorer outcomes (Jester et al., 2023).
• Advanced paternal age and male sex (earlier onset in males).

These factors fit a diathesis-stress model, in which genetic and developmental vulnerability interacts with environmental stressors. Because social determinants affect both onset and outcomes, clinicians should assess them using valid measures and address them in treatment planning (Sturm et al., 2023).

Differential Diagnosis

• Mood disorders with psychotic features: psychosis occurs only during major depressive or manic episodes.
• Schizoaffective disorder: mood episodes present for the majority of the illness, with at least 2 weeks of psychosis without mood symptoms.
• Schizophreniform and brief psychotic disorders: distinguished by duration.
• Delusional disorder: delusions without other prominent psychotic symptoms or marked functional decline.
• Substance-induced psychosis: stimulants, cannabis, hallucinogens and alcohol withdrawal; obtain a toxicology screen.
• Medical conditions: delirium, dementia, seizures, brain tumors, HIV, syphilis, thyroid disease, lupus and anti-NMDA receptor encephalitis.
• Other psychiatric conditions: PTSD, obsessive-compulsive disorder with poor insight, autism spectrum disorder and schizotypal personality disorder (Crawford & Go, 2022).

Assessment

Assessment includes a thorough psychiatric history, collateral information from family, mental status examination, suicide and violence risk assessment, substance use screening and medical workup (complete blood count, metabolic panel, thyroid function, toxicology, HIV and syphilis testing, and neuroimaging or EEG when indicated). Baseline weight, BMI, glucose and lipids should be recorded before starting antipsychotics.

Treatment

• Antipsychotic medication: second-generation antipsychotics are generally first-line; clozapine is recommended for treatment-resistant schizophrenia with required monitoring for neutropenia; long-acting injectables improve adherence and reduce hospitalization (Crawford & Go, 2022).
• Coordinated specialty care for first-episode psychosis combines medication, psychotherapy, family education, case management and supported employment and education. However, use of long-acting injectables and clozapine varies widely across U.S. coordinated specialty care programs, suggesting these effective treatments are underused (Kane et al., 2026).
• Psychosocial interventions: cognitive behavioral therapy for psychosis, family psychoeducation, social skills training, assertive community treatment and supported employment.
• Monitoring: metabolic screening at least annually, assessment for extrapyramidal symptoms and tardive dyskinesia and support for smoking cessation (Crawford & Go, 2022).

Prognosis

Outcomes vary widely. Better prognosis is associated with acute onset, later onset, good premorbid functioning, prominent positive rather than negative symptoms, family support and early treatment. Early intervention during the clinical high-risk and first-episode periods may improve outcomes, although prediction of who will develop psychosis remains imperfect (Forsyth & Bearden, 2023).

Gestalt Therapy: Founders and Techniques

Gestalt therapy was founded by Fritz Perls and Laura Perls, with Paul Goodman, in the 1940s and 1950s; their 1951 book with Ralph Hefferline, Gestalt Therapy, formally introduced the approach. Drawing on Gestalt psychology, existentialism and phenomenology, it emphasizes awareness, personal responsibility and the “here and now,” helping clients recognize unfinished business and how they interrupt contact with themselves and others. Key techniques include the empty chair technique, in which a client speaks to an imagined person or part of the self; the two-chair dialogue between conflicting parts, such as “top dog” and “underdog”; exaggeration of gestures or feelings to heighten awareness; “I” statements and present-tense language to promote responsibility; dream work, in which clients speak as parts of their dreams; and directed awareness exercises focused on bodily sensations and emotions. The therapist acts as an active, authentic partner in the encounter.

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787

Crawford, P., & Go, K. V. (2022). Schizophrenia. American Family Physician, 106(4), 388–396.

Forsyth, J. K., & Bearden, C. E. (2023). Rethinking the first episode of schizophrenia: Identifying convergent mechanisms during development and moving toward prediction. American Journal of Psychiatry, 180(11), 792–804. https://doi.org/10.1176/appi.ajp.20230736

Jester, D. J., Thomas, M. L., Sturm, E. T., Harvey, P. D., Keshavan, M., Davis, B. J., Saxena, S., Tampi, R., Leutwyler, H., Compton, M. T., Palmer, B. W., & Jeste, D. V. (2023). Review of major social determinants of health in schizophrenia-spectrum psychotic disorders: I. Clinical outcomes. Schizophrenia Bulletin, 49(4), 837–850. https://doi.org/10.1093/schbul/sbad023

Kane, J. M., Schooler, N. R., Marcy, P., Brown, C. H., & Robinson, D. G. (2026). Utilization of long-acting injectable antipsychotics and clozapine in coordinated specialty care: Data from EPINET. The Journal of Clinical Psychiatry, 87(4), Article 26m16461.

Perls, F., Hefferline, R. F., & Goodman, P. (1951). Gestalt therapy: Excitement and growth in the human personality. Julian Press.

Sturm, E. T., Thomas, M. L., Sares, A. G., Dave, S., Baron, D., Compton, M. T., Palmer, B. W., Jester, D. J., & Jeste, D. V. (2023). Review of major social determinants of health in schizophrenia-spectrum disorders: II. Assessments. Schizophrenia Bulletin, 49(4), 851–866. https://doi.org/10.1093/schbul/sbad024

More model assignments posted today

• DNP project implementation results
• Trichomoniasis case analysis
• AKI and CKD case study
• HRM 200 orientation presentation
• Pricing tactics assignment
• Disruptive innovation examples
• MAN 4301 HR strategy presentation
• Housing First community psychology paper
• ADHD case study: Larry Wen